Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Materials (Basel, Switzerland)|April 5, 2018
Cross-Linked Poly(vinylidene fluoride-co-hexafluoropropene) (PVDF-co-HFP) Gel Polymer Electrolyte for Flexible Li-Ion Battery Integrated with Organic Light Emitting Diode (OLED)Ilhwan Kim, Bong Sung Kim, Seunghoon Nam, et al.
JAMA Oncology|October 20, 2022
Association of High Levels of Antidrug Antibodies Against Atezolizumab With Clinical Outcomes and T-Cell Responses in Patients With Hepatocellular CarcinomaChan Kim, Hannah Yang, Ilhwan Kim, et al.
Materials (Basel, Switzerland)|April 26, 2019
Highly Efficient Nanocarbon Coating Layer on the Nanostructured Copper Sulfide-Metal Organic Framework Derived Carbon for Advanced Sodium-Ion Battery AnodeChiwon Kang, Yongwoo Lee, Ilhwan Kim, et al.
Scientific Reports|September 2, 2017
Prerequisites for the acquisition of mammalian pathogenicity by influenza A virus with a prototypic avian PB2 geneChung-Young Lee, Se-Hee An, Ilhwan Kim, et al.
Cancer Research and Treatment|May 29, 2024
Distinct Characteristics and Changes in Liver Function of Patients with Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab for More Than 1 YearYoungun Kim, Jung Sun Kim, Beodeul Kang, et al.
Eclinicalmedicine|December 1, 2025
Pegylated granulocyte colony-stimulating factor primary prophylaxis versus no prophylaxis in patients with unresectable pancreatic cancer treated with modified-FOLFIRINOX: a randomized, open-label, multicenter, phase 2 trialChoong-Kun Lee, Ilhwan Kim, Dong Hyun Seo, et al.
Cancer Research and Treatment|December 27, 2024
Pemetrexed Maintenance versus Observation in Patients with Advanced Urothelial Carcinoma Who Completed First-line Platinum-based Chemotherapy without Disease Progression (PREMIER, KCSG GU16-05)Inkeun Park, Shinkyo Yoon, Ilhwan Kim, et al.
Cancer Medicine|January 3, 2025
Serum 25-Hydroxyvitamin D Levels and Survival Outcomes in Advanced Biliary Tract Cancer: Results From the NIFTY TrialSo Heun Lee, Jaekyung Cheon, Ilhwan Kim, et al.
Medicine|June 19, 2023
Comparison of prophylactic effects for chemotherapy induced neutropenia between same-day versus next-day administration of pegteograstim (Neurapeg®) in patients treated with chemotherapy regimen composed of day 1 intensive myleosuppressive agent: A randomized phase III clinical trialKwonoh Park, Young-Kyung Jeon, Jung Hoon Kim, et al.
Liver Cancer|February 12, 2024
Thyroid Dysfunction after Atezolizumab and Bevacizumab Is Associated with Favorable Outcomes in Hepatocellular CarcinomaYoung Shin Song, Hannah Yang, Beodeul Kang, et al.
Pageof 4